UTHealth Houston Interventional Psychiatry Fellowship 20 Feb 10:39 AM (last month)
The Interventional Psychiatry Fellowship at UTHealth Houston consists of a year-long advanced clinical and academic experience managing treatment-resistant and complex psychiatric disorders with various advanced therapies. Fellows will receive direct supervision from experienced faculty members, researchers, and leaders in Interventional Psychiatry, a growing field involving invasive and noninvasive brain stimulation technologies and novel pharmacological approaches.
Applicants must complete an ACGME-accredited psychiatry residency program, be qualified to obtain a Texas Medical License, and have passed Steps I, II & III of the USMLE by the time the fellowship begins.
ACGME Accreditation: No
Texas Medical Board Accreditation: Yes
Length of Fellowship: 1 year (July 1, 2025 to June 30, 2026)
Number of Positions: 1
How to Apply
To apply to the Interventional Psychiatry Fellowship: send your completed application, personal statement, CV, and three letters of recommendation to Joao L. de Quevedo, MD, PhD (Joao.L.DeQuevedo@uth.tmc.edu) and Courtney Liddell (Courtney.L.Liddell@uth.tmc.edu).
Applications will be accepted on a rolling basis.
About the Center and Fellowship
https://med.uth.edu/psychiatry/center-for-interventional-psychiatry/
https://med.uth.edu/psychiatry/uthealth-houston-interventional-psychiatry-fellowship/
Program Director:
Joao L. de Quevedo, MD, PhD | Email: Joao.L.DeQuevedo@uth.tmc.edu
Fellowship Coordinator:
Courtney Liddelll | Email: Courtney.L.Liddell@uth.tmc.edu
The post UTHealth Houston Interventional Psychiatry Fellowship appeared first on National Network of Depression Centers.
Save the Date! 2025 National Network of Depression Centers Best Practices for Mood Disorders in Collaboration with Mayo Clinic 9 Dec 2024 2:00 AM (4 months ago)
2025 National Network of Depression Centers Best Practices for Mood Disorders in Collaboration with Mayo Clinic
October 3 – 4, 2025 at the Swissotel in Chicago, Illinois – REGISTRATION COMING SOON
Learn more + pre-register here.
The NNDC Best Practices Conference is aimed at providing clinically relevant updates for the management of mood disorders & associated comorbidities across the lifespan. Topics include updates and clinical pearls on treatment resistant depression and bipolar disorder, new & novel treatments for depression, and when to refer for ketamine, TMS, ECT, psychedelic therapy. The NNDC faculty are active clinicians [psychiatrists, child psychiatrists, clinical psychologists, and advanced practice providers (APRN, CNP, DNP, PA-C)], informed by new research, and committed to meet the mission of NNDC –use the power of our network to advance scientific discovery, and to provide stigma free, evidence-based care to patients with depressive and bipolar illnesses.
Course format is a rich clinical educational environment of engaging lectures of science and stories – case based learning within the context of existing and emerging new research. Breakout seminars will be interactive and emphasize collaborative learning. Attendees will be able to engage with faculty and other learners as they share opportunities and challenges in their practices.
Target Audience
This course is designed for the many disciplines and providers including psychiatrists and primary care providers, psychologists, advanced practice providers, nursing, and pharmacists.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Analyze treatment strategies for major depression in children, adolescents, adults, and geriatric patients.
- Summarize treatment strategies for bipolar disorder in adolescents, adults, and geriatric patients.
- Apply best practices approaches for the treatment of depression and bipolar disorder.
- Identify when to consider a diverse set of treatment options including conventional antidepressants, augmentation strategies, psychotherapy, rapid-acting antidepressants, transcranial magnetic stimulation (TMS), and electroconvulsive therapy.
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
Registration for 2025 is coming soon! See the full conference details on the Mayo Clinic website here.
The post Save the Date! 2025 National Network of Depression Centers Best Practices for Mood Disorders in Collaboration with Mayo Clinic appeared first on National Network of Depression Centers.
Save the Date! Join us at the American Psychiatric Association 2025 Annual Meeting Networking Reception 5 Dec 2024 7:58 AM (4 months ago)
Join us for a networking reception at the American Psychiatric Association 2025 Annual Meeting!
While you’re in town at the APA 2025 Annual meeting, we invite you to join us for a cocktail reception at Bonaventure Brewing in Los Angeles! It will be a valuable evening of:
- Networking and relationship building opportunities with NNDC Member sites, NNDC guests and the NNDC staff
- The ability to meet with industry and biotech partners to discuss clinical trial or study opportunities
- Discuss research, publication, and grant opportunities
- Have a great time with peers in Los Angeles with cocktails / hors d’oeuvres
- Questions? Reach out to Matt Samocki at msamocki@nndc.org or Courtney Soule at csoule@nndc.org
Date: Saturday, May 17, 2025
Time: TBD
Location: Bonaventure Brewing, (inside the Westin), 404 S Figueroa St Ste. 418A, Los Angeles, CA 90071
Registration coming soon!
The post Save the Date! Join us at the American Psychiatric Association 2025 Annual Meeting Networking Reception appeared first on National Network of Depression Centers.
Save the Date: The 2025 NNDC Annual Conference is in Cincinnati, OH September 10-11 1 Dec 2024 10:04 AM (4 months ago)
SAVE THE DATE! | The National Network of Depression Centers (NNDC) is hosting its seventeenth annual conference from September 10-11, 2025 in Cincinnati, OH in collaboration with the University of Cincinnati, the Lindner Center of HOPE and Cincinnati Children’s Hospital Medical Center. The conference will feature the signature blend of biological, psycho-social and systems-level programming that sets the NNDC Annual Conference apart from other major psychiatric CME events.
Join us for a dynamic set of discussions, lectures, collaboration, presentations and more! In between rigorous academic courses, the event will offer plenty of networking opportunities with NNDC members across the nation!
The post Save the Date: The 2025 NNDC Annual Conference is in Cincinnati, OH September 10-11 appeared first on National Network of Depression Centers.
Western Michigan University Homer Stryker M.D. School of Medicine, Van Andel Institute and Western Michigan University Join the NNDC 30 Apr 2024 9:53 AM (11 months ago)
ANN ARBOR, MICHIGAN, April 30, 2024 — Western Michigan University Homer Stryker M.D. School of Medicine (WMed), Van Andel Institute (VAI) and Western Michigan University (WMU) have joined the National Network of Depression Centers (NNDC) as the organization’s newest joint members after a recent vote by the NNDC Board of Directors.
The membership draws on WMed’s expertise in psychiatric diagnosis and treatment, WMU’s excellence in behavioral treatment approaches and VAI’s expertise in research on the next generation of depression diagnostics and therapeutics.
It also builds on a longstanding collaboration between Eric D. Achtyes, M.D., M.S., DFAPA, chair of Western Michigan University Homer Stryker M.D. School of Medicine’s Department of Psychiatry, and Lena Brundin, M.D., Ph.D., a professor in Van Andel Institute’s Department of Neurodegenerative Science. Together, Brundin and Achtyes have led numerous federally funded clinical studies that have revealed powerful new insights into the biological roots of depression. Their findings also are laying the groundwork for an objective blood test to potentially evaluate depression severity and suicide risk.
“We are delighted to join the world-class institutions already a part of the NNDC,” said Achtyes. “We will combine excellence in patient care, biomedicine and psychiatry at WMed with cognitive behavioral therapies for which Western Michigan University is known, along with excellence in basic and translational neuroscience at Van Andel Institute. Reinforcing our collaboration under the NNDC will allow us to make significant contributions in depression care to both the NNDC and the people of West Michigan.”
WMed has oversight for a 50-bed adult, geriatric and adolescent inpatient clinic that sees approximately 10,000 inpatient visits per year, as well as a 10-bed Adolescent Partial Program, an eight-bed dedicated psychiatry emergency department, and provides electroconvulsive therapy (ECT) services at Ascension Borgess Hospital. The program also does more than 1,100 hospital consultations per year at Ascension Borgess Hospital and Bronson Methodist Hospital, and at the WMed Psychiatry Clinic located on the Ascension Borgess Hospital campus, residents and faculty practice side-by-side treating 5,000 patients annually.
“Together, we hope to make significant strides in our understanding of depression through leading-edge research, which we then can translate into actionable care through our clinical partners at Western Michigan University and Homer Stryker M.D. School of Medicine,” Brundin said. “It is an honor to join the National Network of Depression Centers, and we look forward to a fruitful and impactful relationship.”
Located in downtown Grand Rapids, Van Andel Institute is an independent basic and translational research institute that is home to more than 500 scientists, educators and staff. The Institute’s researchers leverage the latest technologies to explore the underpinnings of cancer, neurodegenerative diseases, metabolic disorders, and more. As part of the Department of Neurodegenerative Science, Brundin’s lab investigates the links between inflammation and depression and suicide risk with the goal of informing improved care.
Further, the partnership will allow integration and collaboration with psychotherapy and behavioral sciences for which Western Michigan University is known.
“Western Michigan University and the Department of Psychology are honored to join the National Network of Depression Centers. This collaboration with WMed and VAI is a vital step toward furthering important research, enhancing professional training, and providing clinical services to address the needs of people with depression,” said Jonathan C. Baker, Ph.D., BCBA-D, LBA the Psychology department chair with Western Michigan University. “We look forward to the chance to collaborate with our partners in Southwest Michigan, as well as the whole NNDC Network, toward this common goal.”
This is the NNDC’s first induction and collaboration of three separate member organizations unified as one joint-associate member of the NNDC.
“We are thrilled to welcome Western Michigan University Homer Stryker M.D. School of Medicine, Western Michigan University and Van Andel Institute as the newest joint members of the NNDC,” said Matt Samocki EdD, executive director of the NNDC. “Given their expertise in bio-psychosocial training for students and residents, as well as excellence in basic and translational neuroscience and commitment to furthering healthcare that assists patients of all ages in reaching optimal mental health and well-being, we think they will contribute immensely our network and advancing the lives of those living with depression and other mood disorders.”
The NNDC is a national network of world-class institutions and collaborators united to lift the burden of depression, bipolar and other mental health conditions to advance people’s overall wellness. The organization works to transform people’s lives through innovations in research, driving care solutions and advancing collective community impact.
Now with 26 member sites across the United States, the Network works to address next-generation mental health concerns through focused and collaborative commissions of researchers that include participants from NNDC member Centers of Excellence. The NNDC research priorities represent a shared commitment to further state-of-the-art depression and mental health research and corresponding clinical care.
The NNDC has worked since 2008 to develop and foster connections through a national network in order to advance scientific discovery and provide stigma-free, evidence-based care to people with depressive and other mental health illnesses. The organization looks forward to expanding the network of member sites to further the next chapter of impact, collaboration and growth.
The post Western Michigan University Homer Stryker M.D. School of Medicine, Van Andel Institute and Western Michigan University Join the NNDC appeared first on National Network of Depression Centers.
Join us at the American Psychiatric Association 2024 Annual Meeting Networking Reception 15 Mar 2024 8:17 AM (last year)
Join us for a networking reception at the American Psychiatric Association 2024 Annual Meeting!
While you’re in town at the APA 2024 Annual meeting, we invite you to join us for a cocktail reception at The Cornell Club-New York! It will be a valuable evening of:
- Networking and relationship building opportunities with NNDC Member sites, NNDC guests and the NNDC staff
- The ability to meet with industry and biotech partners to discuss clinical trial or study opportunities
- Discuss research, publication, and grant opportunities
- Have a great time with peers in a nice setting in NYC with cocktails / hors d’oeuvres
- Questions? Reach out to Matt Samocki at msamocki@nndc.org or Courtney Soule at csoule@nndc.org
Date: Saturday, May 4, 2024
Time: 7:00 – 9:30 p.m. EST
Location: The Cornell Club – New York E 44th St. New York, NY 10017
The post Join us at the American Psychiatric Association 2024 Annual Meeting Networking Reception appeared first on National Network of Depression Centers.
National Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder 12 Feb 2024 11:41 AM (last year)
https://www.sciencedirect.com/science/article/abs/pii/S0165032723013691?via%3Dihub
- Mark J. Niciu, University of Iowa Health Care, Department of Psychiatry/Iowa Neuroscience Institute, Iowa City, IA 52242, USA
- Robert C. Meisner, McLean Hospital, Psychiatric Neurotherapeutics Program, 115 Mill St., Belmont, MA 02478, USA and Harvard Medical School, Department of Psychiatry, Boston, MA 02115, USA
- Brent R. Carr, University of Florida College of Medicine, Department of Psychiatry, Gainesville, FL 32610, USA
- Ali A. Farooqui, University of Louisville School of Medicine, Department of Psychiatry and Behavioral Sciences, Louisville, KY 40202, USA
- David Feifel, Kadima Neuropsychiatry Institute, La Jolla, CA 92037, USA and University of California San Diego School of Medicine, La Jolla, CA 92093, USA
- Adam Kaplin, Mira Pharmaceuticals, Baltimore, MD 21205, USA and the Johns Hopkins School of Medicine, Department of Psychiatry and Behavioral Sciences, Baltimore, MD 21205, USA
- Jeremy Kendrick, University of Utah School of Medicine, Department of Psychiatry, University Neuropsychiatric Institute, Salt Lake City, UT 84132, USA
- Christopher D. Schneck, University of Colorado Anschutz Medical Campus, Department of Psychiatry, Helen and Arthur E. Johnson Depression Center, Aurora, CO 80045, USA
- Jennifer L. Vande Voort, Mayo Clinic, Department of Psychiatry and Psychology, Rochester, MN 55905, USA
- Sagar V. Parikh, University of Michigan School of Medicine, Department of Psychiatry and Depression Center, Ann Arbor, MI 48109, USA
Received 18 July 2023, Revised 1 November 2023, Accepted 3 November 2023, Available online 6 November 2023, Version of Record 15 November 2023.
The post National Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder appeared first on National Network of Depression Centers.
Ketamine’s promise for severe depression grows, but major questions remain 12 Feb 2024 11:32 AM (last year)
https://medicalxpress.com/news/2024-02-ketamine-severe-depression-major.html
More information: Sagar V. Parikh et al, Clinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depression, Journal of Affective Disorders (2023). DOI: 10.1016/j.jad.2023.12.033
The post Ketamine’s promise for severe depression grows, but major questions remain appeared first on National Network of Depression Centers.
2024 DBSA Gerald L. Klerman Awards 5 Feb 2024 11:45 AM (last year)
The Gerald L. Klerman Award is the highest honor that DBSA gives to members of the scientific community. Presented each year, this award recognizes researchers whose work advances knowledge of the causes, diagnosis, and treatment of depression and bipolar disorder. Up to two awards are given annually in each of the following two categories: DBSA Gerald L. Klerman Award, Senior Investigator and DBSA Gerald L. Klerman Award, Young Investigator.
Gerald L. Klerman (1928-1992) was an educator, researcher, clinician, author, and administrator who specialized in depression, schizophrenia, and panic and other anxiety disorders. He was also one of DBSA’s earliest supporters. Klerman conducted the first clinical trial showing the efficacy of medication and psychotherapy in preventing recurrent depression and led the first large-scale, multi-site study to understand the diagnosis, course, and genetics of major depression.
From 1966 to 1970 Klerman served on the faculty at Yale University. He subsequently moved to Harvard University where he taught at the medical school and was director of psychiatric research at Massachusetts General Hospital, as well as director of the Eric Lindemann Mental Health Center. He was appointed head of the Alcohol, Drug Abuse and Mental Health Administration from 1977 to 1980 by President Jimmy Carter, and then became professor of psychiatry and vice chairman of research at Cornell Medical College and New York Hospital. He was the author of numerous articles and books.
Awards are given in each of the following two categories:
- The Gerald L. Klerman Young Investigator Award recognizes early career contributions. Nominees must be within 15 years of the completion of their highest degree at the time of nomination. See submission form for more details.
- The Gerald L. Klerman Senior Investigator Award recognizes lifetime contributions. See submission form for more details.
The NNDC encourages you to share this information with your colleagues who may have an interest. Let’s make sure the thought leaders in this critical field of research continue to be recognized for their valuable contributions. The deadline for nominations is Tuesday, February 20th.
See details on Dr. Klerman, including a list of past winners.
The post 2024 DBSA Gerald L. Klerman Awards appeared first on National Network of Depression Centers.
Announcement: Courtney Soule, Director of Membership, Development, and Public Relations 22 Jan 2024 6:00 AM (last year)
Official Press Release
National Network of Depression Centers Announces Courtney Soule as Director of Membership, Development, and Public Relations
ANN ARBOR, MICHIGAN, January 20, 2024 – The National Network of Depression Centers (NNDC) is pleased to announce the appointment of Courtney Soule as the organization’s new director of Membership, Development, and Public Relations starting February 1, 2024.
Soule brings more than 20 years of experience and passion to the organization and has dedicated the last three and a half years to advancing regional and mental health initiatives with the Great Lakes Bay Regional Alliance and the Great Lakes Bay Region Mental Health Partnership to create positive change in the community.
The voice behind the organization’s iMatter Anti-Stigma Campaign, she has a long-standing commitment to advocacy, reducing stigma and is passionate about supporting the need for further awareness of mental health.
Prior to her role with the Alliance, Soule was the managing editor of a community publication and worked in several aspects of community development. She also had a 15-year career at Dow that spanned public affairs, government affairs, public policy, and corporate strategic development.
“Courtney will be a key component of our work in lifting the burden on those that are impacted by depression and other mental health illnesses on a national scale. Her experience is vital to providing support to our existing NNDC member centers and opening the door for additional partnerships and growth opportunities,” said Dr. Matt Samocki, executive director of the NNDC. “Given her previous work in mental health and wellbeing, we see tremendous potential for the organization as we work towards eliminating stigma and transforming awareness and access to evidence-based care.”
In this role, Soule will be responsible for supporting various aspects of the NNDC’s work, with a focus on membership attraction and retention, revenue growth, and the development and implementation of public relations strategies. Her role plays a pivotal part in achieving the NNDC’s goals outlined in the current strategic plan and beyond.
“We are thrilled to see Courtney take on this dynamic and challenging role at the national level working to advance mental health and wellbeing on a broader scale with the NNDC,” said Matt Felan, president and CEO of the Great Lakes Bay Regional Alliance. “Her contributions have been invaluable over the last several years throughout the region and while we regret to see her leave the Alliance and the Mental Health Partnership, this is an amazing opportunity in the development of mental health and one we know that the region can prosper from through continued future collaboration.”
The NNDC has worked since 2008 to develop and foster connections through a national network in order to advance scientific discovery and provide stigma-free, evidence-based care to people with depressive and other mental health illnesses. This appointment supports the organization’s next chapter of impact, collaboration, and growth.
The post Announcement: Courtney Soule, Director of Membership, Development, and Public Relations appeared first on National Network of Depression Centers.